• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly.

Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.


Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration (FDA) has approved TRIKAFTA™ (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF) in people ages 12 years and...

Read more →
Aptar’s Activ-Blister™ Packaging Solution

Aptar’s Activ-Blister™ Packaging Solution Approved by U.S. FDA for Oral Solid Dose HIV Prevention Medicine

AptarGroup, Inc., a global leader in consumer dispensing, active packaging and drug delivery solutions, today announced that its Activ-Blister™ packaging solution for oral solid dose drug delivery was recently approved by the U.S. Food and Drug Administration (FDA) for a HIV prevention medicine.

Read more →
Naltrexone Therapy

Delpor to Tackle Opioid Use Disorder with $5.7 Million NIH HEAL Grant Award for the Development of a Once-Yearly Naltrexone Therapy to Prevent Relapses

Delpor, Inc., a clinical stage life sciences company that utilizes innovative technologies in order to develop once yearly therapies for chronic conditions, announced that the National Institutes of Health (NIH) has awarded the company a grant for the development of a Once-Yearly Naltrexone product for the prevention of relapse to opioid dependence.

Read more →

We use cookies to ensure you get the best experience on this website Privacy Policy